Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGJT9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,985
Award facts
- Contract value 100% obligated
- $4,985.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $4,985.28 to DMS Pharmaceutical Group Inc. on January 8, 2026, for the supply of BOTOX 200 unit vials. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly against all qualified vendors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor for military medical operations globally. The company's extensive portfolio of pharmaceutical products and demonstrated performance on numerous prior delivery orders establish its capability to fulfill specialized medical requirements for federal military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FGJT9?
SPE2DR26FGJT9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FGJT9 worth?
The government has obligated $4,985 on SPE2DR26FGJT9.
Is contract SPE2DR26FGJT9 an order under another contract?
Yes. SPE2DR26FGJT9 is a delivery order under SPE2DR25D9832, an indefinite delivery contract.
Was contract SPE2DR26FGJT9 competed?
The extent of competition for SPE2DR26FGJT9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award